» Articles » PMID: 24053175

Dissociation of FK506-binding Protein 12.6 KD from Ryanodine Receptor in Bronchial Smooth Muscle Cells in Airway Hyperresponsiveness in Asthma

Overview
Date 2013 Sep 24
PMID 24053175
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Airway hyperresponsiveness (AHR) in asthma is predominantly caused by increased sensitivity of bronchial smooth muscle cells (BSMCs) to stimuli. The sarcoplasmic reticulum (SR)-Ca(2+) release channel, known as ryanodine receptor (RyR), mediates the contractive response of BSMCs to stimuli. FK506-binding protein 12.6 kD (FKBP12.6) stabilizes the RyR2 channel in a closed state. However, the interaction of FKBP12.6 with RyR2 in AHR remains unknown. This study examined the interaction of FKBP12.6 with RyR2 in BSMCs in AHR of asthma. The interaction of FKBP12.6 with RyR2 and FKBP12.6 expression was determined in a rat asthma model and in BSMCs treated with inflammatory cytokines. The calcium responses to contractile agonists were determined in BSMCs with overexpression and knockdown of FKBP12.6. Asthmatic serum, IL-5, IL-13, and TNF-α enhance the calcium response of BSMCs to contractile agonists and cause dissociation of FKBP12.6 from RyR2 and a decrease in FKBP12.6 gene expression in BSMCs in culture and in ovalbumin (OVA)-sensitized and -challenged rats. Knockdown of FKBP12.6 in BSMCs causes a decrease in the association of RyR2 with FKBP12.6 and an increase in the calcium response of BSMCs. Overexpression of FKBP12.6 increases the association of FKBP12.6 with RyR2, decreases the calcium response of BSMCs, and normalizes airway responsiveness in OVA-sensitized and -challenged rats. Dissociation of FKBP12.6 from RyR2 in BSMCs is responsible for the increased calcium response contributing to AHR in asthma. Manipulating the interaction of FKBP12.6 with RyR2 might be a novel and useful treatment for asthma.

Citing Articles

Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis.

Steagall W, Stylianou M, Pacheco-Rodriguez G, Yu Z, Moss J ERJ Open Res. 2023; 9(4).

PMID: 37589458 PMC: 10423980. DOI: 10.1183/23120541.00305-2023.


Reciprocal Correlations of Inflammatory and Calcium Signaling in Asthma Pathogenesis.

Okonski R, Zheng Y, Di Mise A, Wang Y Adv Exp Med Biol. 2021; 1303:319-331.

PMID: 33788200 DOI: 10.1007/978-3-030-63046-1_17.


Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.

Wang L, Ginnan R, Wang Y, Zheng Y Adv Exp Med Biol. 2021; 1303:305-317.

PMID: 33788199 DOI: 10.1007/978-3-030-63046-1_16.


Airway smooth muscle and airway hyperresponsiveness in asthma: mechanisms of airway smooth muscle dysfunction.

Gebski E, Anaspure O, Panettieri R, Koziol-White C Minerva Med. 2021; 113(1):4-16.

PMID: 33496164 PMC: 9254130. DOI: 10.23736/S0026-4806.21.07283-9.


TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells.

Ramu S, Calven J, Michaeloudes C, Menzel M, Akbarshahi H, Chung K ERJ Open Res. 2020; 6(4).

PMID: 33043044 PMC: 7533303. DOI: 10.1183/23120541.00147-2020.


References
1.
Mitchell R, Ruhlmann E, Magnussen H, Leff A, Rabe K . Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol. 1994; 267(2 Pt 1):L218-22. DOI: 10.1152/ajplung.1994.267.2.L218. View

2.
Sanderson M, Delmotte P, Bai Y, Perez-Zogbhi J . Regulation of airway smooth muscle cell contractility by Ca2+ signaling and sensitivity. Proc Am Thorac Soc. 2007; 5(1):23-31. DOI: 10.1513/pats.200704-050VS. View

3.
Matsumoto H, Hirata Y, Otsuka K, Iwata T, Inazumi A, Niimi A . Interleukin-13 enhanced Ca2+ oscillations in airway smooth muscle cells. Cytokine. 2011; 57(1):19-24. DOI: 10.1016/j.cyto.2011.10.014. View

4.
Nakazawa T, Takasawa S, Noguchi N, Nata K, Tohgo A, Mori M . Genomic organization, chromosomal localization, and promoter of human gene for FK506-binding protein 12.6. Gene. 2005; 360(1):55-64. DOI: 10.1016/j.gene.2005.07.004. View

5.
Simon H, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K . Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 1997; 158(8):3902-8. View